QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-nexgel-q2-eps-009-misses-007-estimate-sales-2884m-miss-3080m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 2...

 an-overview-of-nexgels-earnings
An Overview of NexGel's Earnings
08/11/2025 19:04:35

 nexgel-expands-partnership-with-stada-to-launch-new-digestive-and-skin-care-products-receives-1m-non-dilutive-funding

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-wat...

 nexgel-q1-eps-009-beats-010-estimate-sales-281m-beat-273m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 ...

 nexgel-expects-q4-2024-revenue-at-3m-fy24-total-revenue-86m-predicts-13m-revenue-for-2025-cash-flow-positive-highlights-growth-in-contract-manufacturing-consumer-products

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, ...

 nexgel-q3-eps-011-misses-010-estimate-sales-294m-beat-285m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 1...

 nexgel-preliminary-revenue-for-q3-2024-of-285m-an-increase-of-133-yoy-as-well-as-an-increase-of-30-over-the-companys-previously-issued-july-q3-revenue-guidance-of-220m

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-c...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION